Immix reports promising response rate with IMX-110 in first-line therapy-resistant STS mouse study Jan. 13, 2022
Lantern Pharma expands collaboration with NCI to support progression of LP-184 and LP-284 Jan. 13, 2022
New isomeric aza-analogues of natural jaspine B: synthesis and in vitro antiproliferative activity Jan. 13, 2022
A simple method for the synthesis of isoxazole derivatives with in vitro antitumor activity Jan. 12, 2022
RSS